Novo issues loan to Orexo for increased stake
This article was originally published in Scrip
Executive Summary
Novo, a majority shareholder of Novo Nordisk and Novozymes, has acquired a 10.7% stake in the Swedish pharmaceutical company Orexo as part of a bond issue.